# Seizure Activity in Alzheimer's Disease

> **NCT01554683** · NA · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Alzheimer's Disease
- Seizures

## Interventions

- **DRUG:** Low/High/Placebo Dose Keppra (Levetiracetam)

## Key facts

- **NCT ID:** NCT01554683
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2017-07-01
- **Final completion:** 2017-07-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01554683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01554683, "Seizure Activity in Alzheimer's Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01554683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*